Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
AUTOR(ES)
Sperb-Ludwig, Fernanda
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
14/11/2019
RESUMO
Abstract Mucolipidosis II and III (ML II and III) alpha/beta and ML III gamma are lysosomal diseases caused by GlcNAc-1-phosphotransferase deficiency. Previous data indicate that MLII patients have functionally impaired immune system that contributes to predisposition to infections.We evaluated the immunological phenotype of three Brazilian patients with ML III gamma. Our data suggest that the residual activity of GlcNAc-1-phosphotransferase in patients with ML III gamma is enough to allow the targeting of the lysosomal enzymes required for B-cell functions maintenance.
Documentos Relacionados
- Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome
- Oral findings in patients with mucolipidosis type III
- Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel.
- Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection.
- Cellular and humoral immune response to a phenolic glycolipid antigen (PhenGL-I) in patients with leprosy.